According to FutureWise analysis the market for non-alcoholic steatohepatitis clinical trials in 2023 is US$ 2.73 billion, and is expected to reach US$ 4.6 billion by 2031 at a CAGR of 6.70%.
Growing obesity and diabetes rates, mainly due to sedentary lifestyles, and unmet medical needs can be attributed to the growth of the industry. The development of Non-alcoholic Steatohepatitis (NASH) may take years for patients with non-alcoholic fatty liver disease (NAFLD). Developing clinically useful animal models and pharmaceutical therapies for NASH has been hampered by the lack of sensitive, non-invasive diagnostic methods. Due to pathologist bias, it can be challenging to categorize patients into distinct fibrosis stages in NASH trials. With the Phase IIb nonalcoholic steatohepatitis (NASH) trial, Sagimet Biosciences is using digital pathology to achieve more consistent biopsy analysis. An integral part of digital pathology in NASH is histological imaging of biopsy specimens, which is analyzed with artificial intelligence (AI) in order to detect fibrosis alterations.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Non-alcoholic Steatohepatitis Clinical Trials Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Non-alcoholic Steatohepatitis Clinical Trials Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.